Innoviva Inc. INVA
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Innoviva Inc. is an innovative pharmaceutical company, focusing primarily on managing royalty portfolios that originate from collaborations with external partners. This asset plays a significant role in the healthcare sector, specifically within the pharmaceuticals and biotechnology industries. The company is involved …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees159
TickerINVA
Statistics
Market Cap$1.67B
Revenue (TTM)$411.3M
Net Income$271.2M
Net Margin65.9%
EPS$3.30
P/E3.58
P/S3.94
P/B1.23
EV/EBITDA7.35
ROE50.7%
Dividend Yield4.43%
Price$22.59
Data: Twelve Data · Revenue = mcap / P/S